Question 1

What is this medicine for, and how does it work?

Accepted Answer

This is an anti-cancer medication. It's used to treat mantle cell lymphoma. It works by inhibiting an enzyme involved in cancer cell growth and division.

Question 2

When and how should this medicine be taken?

Accepted Answer

• Take with or without food • Take at 12-hour intervals • Swallow capsule whole • Take with water

Question 3

When should this medicine not be used?

Accepted Answer

• Serious bleeding • Infections • Heart rhythm problems • Headache

Question 4

What precautions should be taken before using this medicine?

Accepted Answer

• Can cause serious bleeding, use caution with blood thinners • May increase risk of infections, monitor for signs of infection • Can cause heart rhythm problems, use caution in patients with heart conditions • May cause headache and diarrhea

Question 5

Is it safe to use this medicine during pregnancy?

Accepted Answer

• May cause fetal harm • Advise pregnant women of potential risk • Use effective contraception during treatment

Question 6

Can this medicine be used while breastfeeding?

Accepted Answer

• Can cause serious bleeding, use caution with blood thinners • May increase risk of infections, monitor for signs of infection • Can cause heart rhythm problems, use caution in patients with heart conditions • May cause headache and diarrhea

Question 7

What should be done if a dose is missed?

Accepted Answer

• If you miss a dose, take it as soon as you remember. • However, if it's almost time for your next dose, skip the missed dose. • Never take two doses together. • For once-daily dosing: If you remember on the same day, take the dose. • For twice-daily dosing: If more than 8 hours until your next dose, take the missed dose. • Take your next dose at the regular time. • If you miss multiple doses, contact your doctor.

Question 8

What should be done in case of an overdose?

Accepted Answer

• Symptoms: Bleeding, atrial fibrillation. • Treatment: Bleeding control, cardiac monitoring.

Question 9

What should be done if side effects are experienced?

Accepted Answer

• Common side effects: Low blood counts, headache, diarrhea, muscle pain • What to do: Regular blood tests; Report unusual bleeding; Stay hydrated; Monitor symptoms; Stop taking the medication and seek medical advice if any severe side effect or unusual symptoms occur.

Question 10

What medical indications are treated with Acalabrutinib?

Accepted Answer

Acalabrutinib is a pharmaceutical active substance.

Question 11

What is the recommended dosage for Acalabrutinib?

Accepted Answer

Standard adult dosage: by mouth – 100 mg (every twelve hours). Pediatric dosage: No approved dosage available. Always consult a registered physician for individualized dosage adjustments based on clinical assessment.

Question 12

Is Acalabrutinib safe during pregnancy and breastfeeding?

Accepted Answer

Acalabrutinib is classified under Pregnancy Category "Not Assigned". Always consult your healthcare provider or OB/GYN before taking this medication during pregnancy or lactation.

Question 13

What are the common side effects of Acalabrutinib?

Accepted Answer

**More than 10%**; **All grades**; Decreased hemoglobin (46%);Decreased platelets (44%);Headache (39%);Decreased neutrophils (36%);Diarrhea (31%);Fatigue (28%);Myalgia (21%);Bruising (21%);Nausea (19%);Rash (18%);Abdomin

Clinical Information	Administration Information
Indication: Mantle Cell Lymphoma Condition: Patients who have received greater than or equal to 1 prior therapy	Dose: by mouth – 100 mg Frequency: every twelve hours Note: Continue until disease progression or unacceptable toxicity
Indication: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Condition: Monotherapy	Dose: by mouth – 100 mg Frequency: every twelve hours Note: Continue until disease progression or unacceptable toxicity

Clinical Information	Administration Information
Condition: Renal impairment Mild-to-moderate (eGFR greater than 30 mL/min/1.73m²)	Dose: Tablet – No clinically relevant pharmacokinetics difference observed Note: No dosage adjustment required
Condition: Renal impairment Severe (eGFR less than 30 mL/min/1.73m²) or patients on dialysis	Dose: Tablet – Acalabrutinib pharmacokinetics has not been evaluated Note: Evaluation not available for severe impairment or dialysis patients

Drug Name	Risk Factors
CYP3A inhibitors	Expected to increase acalabrutinib systemic exposure
CYP3A inducers	Expected to decrease acalabrutinib systemic exposure

Medicine Overview

Indication

What is this medicine for, and how does it work?

When and how should this medicine be taken?

When should this medicine not be used?

What precautions should be taken before using this medicine?

Is it safe to use this medicine during pregnancy?

Can this medicine be used while breastfeeding?

What should be done if a dose is missed?

What should be done in case of an overdose?

What should be done if side effects are experienced?

Adult Dose

Child Dose

Renal Dose

Drug Interaction

Disease Interaction

Pregnancy

Data Sources